文献速递腹部CT

CT在预测胃癌新辅助化疗后病理完全缓解中的作用

Role of CT in the prediction of pathological complete response in gastric cancer after neoadjuvant chemotherapy.
PubMed 文献 · Abdom Radiol (NY) · 2021-02-10

本研究回顾性分析199例胃癌根治术后患者,其中11例(ypT0N0)为病理完全缓解(pCR)组,按1:4匹配44例非pCR患者共55例分析。二元logistic回归显示化疗后最大淋巴结短径和肿瘤厚度缩减比是pCR的独立预测因素,ROC曲线分析AUC为0.94。

要点

  • 化疗后最大淋巴结短径和肿瘤厚度缩减比是胃癌新辅助化疗后pCR的独立预测因素。
  • 两特征联合预测pCR的AUC达0.94。
  • 研究纳入199例中仅11例达pCR,pCR组与非pCR组按1:4匹配后共55例分析。

核心结论

  • 化疗后最大淋巴结短径和肿瘤厚度缩减比这两个CT特征可较好地预测胃癌患者新辅助化疗后的pCR。

研究设计与样本

  • 回顾性研究,复习机构数据库2010年1月至2013年12月接受新辅助化疗后手术切除的胃腺癌患者,199例中11例达ypT0N0为pCR组,按1:4匹配44例非pCR患者,共分析55例。

关键影像表现/征象

  • 化疗后最大淋巴结短径和肿瘤厚度缩减比是pCR的独立预测因素。
  • 基于上述两特征的ROC曲线分析AUC为0.94。

诊断标准与关键数值

  • pCR定义为ypT0N0。
  • 化疗后最大淋巴结短径和肿瘤厚度缩减比联合预测pCR的AUC为0.94。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore which computed tomography (CT) features can predict pathological complete response (pCR) (ypT0N0) after neoadjuvant chemotherapy (NAC) in patients with gastric adenocarcinoma (GC).

MATERIALS AND METHODS: This study reviewed an institutional database of patients who underwent resection of GC after NAC and identified patients with pCR from January 2010 to December 2013. The correlations between pre-chemotherapy and post-chemotherapy CT features and pCR were analyzed.

RESULTS: Eleven of 199 patients with GC who achieved ypT0N0 status after NAC were classified as the pCR group in this study. After matching pCR (n = 11) and non-pCR patients (n = 44) in the ratio of 1:4, a total of 55 cases were analyzed. The binary logistic regression analysis showed that the post-chemotherapy short diameter of the largest lymph node and tumor thickness ratio reduction were independent predictors of pCR, with an area under the curve (AUC) of 0.94 on the receiver operating characteristic (ROC) curve analysis.

CONCLUSION: Two CT features, including the short diameter of the largest lymph node post-chemotherapy and tumor thickness ratio reduction, are good predictors of pCR after NAC in patients with GC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wang ZL, Li YL, Li XT, et al. Role of CT in the prediction of pathological complete response in gastric cancer after neoadjuvant chemotherapy. Abdom Radiol (NY). 2021. PMID: 33566165. doi:10.1007/s00261-021-02967-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。